Skip to main content

Find Clinical Trials

Home
Conditions
Urothelial Carcinoma

Clinical trial condition

Urothelial Carcinoma

Explore clinical trials studying Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

243 public trials 72 recruiting studies

Refine in advanced search Browse all conditions

Urothelial Carcinoma trial results

Recruiting

Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)

NCT07241793

Conditions: Advanced Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +5 more
Locations: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China

Sun yat-sen university cancer center Guangzhou, Guangdong, China

The fifth Affiliated Hospital of Guangzhou Medcial University Guangzhou, Guangdong, China

Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Urothelial Carcinoma(PANKU-Bladder01)

NCT06857175

Conditions: Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

NCT07322263

Conditions: BCG-Refractory Bladder Cancer, BCG-Unresponsive Bladder Cancer, Bladder Cancer, +25 more
Locations: University of Iowa Iowa City, Iowa, United States

View Trial Details

Recruiting

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

NCT06451497

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +58 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

NEXT Oncology Austin, TX 78758, Texas, United States

NEXT Oncology San Antonio, Texas, United States

View Trial Details

Recruiting

Trastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresectable Locally Advanced or Metastatic Biliary Tract Cancer or Urothelial Carcinoma After Failure of Standard Therapy

NCT07506057

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +10 more
Locations: The First Affiliated Hospital of China Medical University Shenyang, Liaoning, China

View Trial Details

Recruiting

Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma

NCT07492628

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
Locations: Peking University Shenzhen Hospital Shenzhen, Guangdong, China

View Trial Details

Recruiting

Bio Clinical Collection of Urothelial Carcinoma

NCT04970472

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations: Rangueil University Hospital Toulouse, France

View Trial Details

Recruiting

Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma

NCT05321316

Conditions: Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy

NCT07234968

Conditions: Bladder Cancer, Bladder Neoplasm, Bladder Transitional Cell Carcinoma, +20 more
Locations: Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States

Jefferson Einstein Philadelphia Hospital Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

NCT06138561

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details